Nechifor M, Ciubotariu Diana
Pharmacology Department, Faculty of Dental Medicine, University of Medicine and Pharmacy "Grigore T. Popa"--Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):552-6.
The imidazoline system consists in imidazoline receptors I1, I2 and I3 and the active as well as that there are some endogenous ligands. We consider that one of the most important functions of this system is modulation of different types of behavior. Existent data show that I1 and I2 receptors have different effects on some behavior components, such as suicidal behavior, stress, anxiety, food intake etc. We consider that selective I1 and I2 agonists could become drugs to be used in the therapy of some behavioral disorders. The fact that some agonists or antagonists of imidazoline receptors have also effect on alpha-adrenergic receptors or MAO (monoamine oxidase) enlarges the use area of the compounds in behavioral disorders.
咪唑啉系统由咪唑啉受体I1、I2和I3以及活性物质组成,并且存在一些内源性配体。我们认为该系统最重要的功能之一是对不同类型行为的调节。现有数据表明,I1和I2受体对某些行为成分有不同影响,如自杀行为、应激、焦虑、食物摄入等。我们认为选择性I1和I2激动剂可能成为用于治疗某些行为障碍的药物。咪唑啉受体的一些激动剂或拮抗剂也对α-肾上腺素能受体或单胺氧化酶(MAO)有作用,这一事实扩大了这些化合物在行为障碍中的应用范围。